Holbrook, A.M. (2018) “PERSONALIZED BENEFIT-HARM INFORMATION INFLUENCES PATIENT DECISIONS REGARDING WARFARIN”, Journal of Population Therapeutics and Clinical Pharmacology, 20(3). Available at: https://mail.jptcp.com/index.php/jptcp/article/view/370 (Accessed: 19 November 2024).